NCT00003556View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Melanoma

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

May 31, 2001

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

ALVAC-hB7.1

BIOLOGICAL

canarypox-hIL-12 melanoma vaccine

Trial Locations (1)

35294

University of Alabama Comprehensive Cancer Center, Birmingham

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00003556 - Vaccine Therapy in Treating Patients With Melanoma | Biotech Hunter | Biotech Hunter